Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | FGFR3 |
| Variant | S371C |
| Impact List | missense |
| Protein Effect | gain of function |
| Gene Variant Descriptions | FGFR3 S371C lies within the extracellular domain of the Fgfr3 protein (UniProt.org). S371C confers a gain of function to the Fgfr3 protein as demonstrated by dimerization, constitutive activation, increased MAPK pathway signaling (PMID: 12009017), a growth advantage relative to wild-type Fgfr3 in a competition assay, and increased transformation activity in cultured cells (PMID: 34272467). |
| Associated Drug Resistance | |
| Category Variants Paths |
FGFR3 mutant FGFR3 act mut FGFR3 S371C |
| Transcript | NM_000142.5 |
| gDNA | chr4:g.1804365A>T |
| cDNA | c.1111A>T |
| Protein | p.S371C |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| XM_011513422.2 | chr4:g.1804365A>T | c.1111A>T | p.S371C | RefSeq | GRCh38/hg38 |
| NM_001354809.1 | chr4:g.1804365A>T | c.1111A>T | p.S371C | RefSeq | GRCh38/hg38 |
| XM_011513422 | chr4:g.1804365A>T | c.1111A>T | p.S371C | RefSeq | GRCh38/hg38 |
| NM_001354810.2 | chr4:g.1804365A>T | c.1111A>T | p.S371C | RefSeq | GRCh38/hg38 |
| XM_006713873 | chr4:g.1804365A>T | c.1111A>T | p.S371C | RefSeq | GRCh38/hg38 |
| NM_001354809.2 | chr4:g.1804365A>T | c.1111A>T | p.S371C | RefSeq | GRCh38/hg38 |
| XM_006713873.2 | chr4:g.1804365A>T | c.1111A>T | p.S371C | RefSeq | GRCh38/hg38 |
| XM_011513420.1 | chr4:g.1804365A>T | c.1111A>T | p.S371C | RefSeq | GRCh38/hg38 |
| XM_006713873.1 | chr4:g.1804365A>T | c.1111A>T | p.S371C | RefSeq | GRCh38/hg38 |
| XM_047449823.1 | chr4:g.1804365A>T | c.1111A>T | p.S371C | RefSeq | GRCh38/hg38 |
| XM_011513420 | chr4:g.1804365A>T | c.1111A>T | p.S371C | RefSeq | GRCh38/hg38 |
| XM_047449822.1 | chr4:g.1804365A>T | c.1111A>T | p.S371C | RefSeq | GRCh38/hg38 |
| XM_011513420.2 | chr4:g.1804365A>T | c.1111A>T | p.S371C | RefSeq | GRCh38/hg38 |
| NM_000142.4 | chr4:g.1804365A>T | c.1111A>T | p.S371C | RefSeq | GRCh38/hg38 |
| XM_047449824.1 | chr4:g.1804365A>T | c.1111A>T | p.S371C | RefSeq | GRCh38/hg38 |
| XM_006713872 | chr4:g.1804365A>T | c.1111A>T | p.S371C | RefSeq | GRCh38/hg38 |
| XM_011513422.1 | chr4:g.1804365A>T | c.1111A>T | p.S371C | RefSeq | GRCh38/hg38 |
| NM_001354810.1 | chr4:g.1804365A>T | c.1111A>T | p.S371C | RefSeq | GRCh38/hg38 |
| NM_000142.5 | chr4:g.1804365A>T | c.1111A>T | p.S371C | RefSeq | GRCh38/hg38 |
| NM_000142 | chr4:g.1804365A>T | c.1111A>T | p.S371C | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|